|
| | Publication Year | Title | Author(s) |
| 1 | 13-Feb-2024 | Utility of FDG-PET in predicting the histology of relapsed or refractory lymphoma. | Wai, Shin Hnin; Lee, Sze Ting ; Cliff, Edward Robert Scheffer; Bei, Michael; Lee, Jiwoo; Hawkes, Eliza A ; Chong, Geoffrey |
| 2 | May-2023 | Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP study. | Manos, Kate ; Chong, Geoffrey ; Keane, Colm; Lee, Sze Ting ; Smith, Charmaine; Churilov, Leonid ; McKendrick, Joseph; Renwick, William; Blombery, Piers; Burgess, Melinda; Nelson, Niles Elizabeth; Fancourt, Tineke ; Hawking, Joanne; Lin, Wendi; Scott, Andrew M ; Barraclough, Allison ; Wight, Joel C ; Grigg, Andrew P ; Fong, Chun Yew ; Hawkes, Eliza A |
| 3 | 30-Oct-2021 | Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study. | Wang, Michael T ; Ramchandren, Radhakrishnan; Chen, Robert; Karlin, Lionel; Chong, Geoffrey ; Jurczak, Wojciech; Wu, Ka Lung; Bishton, Mark; Collins, Graham P; Eliadis, Paul; Peyrade, Frédéric; Lee, Yihua; Eckert, Karl; Neuenburg, Jutta K; Tam, Constantine S |
| 4 | 8-Jul-2021 | Predicting primary treatment failure using interim FDG-PET scanning in Diffuse large B-cell lymphoma. | Wight, Joel C ; Wai, Shin Hnin; Shen, Edward; Lee, Sze Ting ; Berlangieri, Salvatore U ; Fancourt, Tineke ; Hawkes, Eliza A ; Hannah, Anthony; Leung, Teresa; Chong, Geoffrey |
| 5 | May-2021 | Evolution of eligibility criteria for diffuse large B-cell lymphoma randomised controlled trials over 30 years. | Loh, Zoe ; Salvaris, Ross; Chong, Geoffrey ; Churilov, Leonid ; Manos, Kate ; Barraclough, Allison ; Hawkes, Eliza A |
| 6 | 15-Apr-2021 | Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study. | Mooi, Jennifer K ; Chionh, Fiona; Savas, Peter; Da Gama Duarte, Jessica; Chong, Geoffrey ; Brown, Stephen; Wong, Rachel; Price, Timothy J; Wann, Alysson ; Skrinos, Effie; Mariadason, John M ; Tebbutt, Niall C |
| 7 | Feb-2021 | Use of Ultrasonography Facilitates Noninvasive Evaluation of Lymphadenopathy in a Lymph Node Diagnostic Clinic. | Loh, Zoe ; Hawkes, Eliza A ; Chionh, Fiona; Azad, Arun; Chong, Geoffrey |
| 8 | 29-Jan-2021 | Dual anti-angiogenesis agents bevacizumab plus trebananib, without chemotherapy, in first-line treatment of metastatic colorectal cancer: results of a phase II study. | Mooi, Jennifer K ; Chionh, Fiona; Savas, Peter; Da Gama Duarte, Jessica; Chong, Geoffrey ; Brown, Stephen; Wong, Rachel; Price, Timothy; Wann, Alysson ; Skrinos, Effie; Mariadason, John M ; Tebbutt, Niall C |
| 9 | Nov-2020 | Routine Blood Tests in Asymptomatic Patients With Indolent Lymphoma Have Limited Ability to Detect Clinically Significant Disease Progression. | Piercey, Oliver A; Loh, Zoe ; Chan, Joanna; Chong, Geoffrey ; Grigg, Andrew P ; Cheema, Steven ; Gill, Gurjot; Whybird, Matthew; Cushion, Tania; Hawkes, Eliza A |
| 10 | Aug-2020 | Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma. | Lenz, Georg; Hawkes, Eliza A ; Verhoef, Gregor; Haioun, Corinne; Thye Lim, Soon; Seog Heo, Dae; Ardeshna, Kirit; Chong, Geoffrey ; Haaber, Jacob; Shi, Wei; Gorbatchevsky, Igor; Lippert, Susanne; Hiemeyer, Florian; Piraino, Paolo; Beckmann, Georg; Peña, Carol; Buvaylo, Viktoriya; Childs, Barrett H; Salles, Gilles |
| 11 | Mar-2020 | Occult Gastrointestinal Perforation in a Patient With EGFR-Mutant Non-Small-Cell Lung Cancer Receiving Combination Chemotherapy With Atezolizumab and Bevacizumab: Brief Report. | Gunjur, Ashray ; Chong, Geoffrey ; Lim, Adeline ; Lau, Eddie ; Mitchell, Paul L R ; John, Thomas ; Arulananda, Surein |
| 12 | Jan-2020 | Patient selection and tolerability of high-dose methotrexate as central nervous system prophylaxis in diffuse large B-cell lymphoma. | Garwood, Melissa J; Hawkes, Eliza A ; Churilov, Leonid ; Chong, Geoffrey |
| 13 | Oct-2019 | Comprehensive geriatric assessment is useful in an elderly Australian population with diffuse large B-cell lymphoma receiving rituximab-chemotherapy combinations. | Ong, Doen Ming; Ashby, Michael; Grigg, Andrew P ; Gard, Grace; Ng, Zi Y; Huang, Huayi Ellen; Chong, Yee Shuen; Cheah, Chan Yoon; Devitt, Bianca; Chong, Geoffrey ; Loh, Zoe ; Mo, Allison ; Hawkes, Eliza A |
| 14 | Jun-2019 | Eculizumab therapy in gemcitabine-induced thrombotic microangiopathy in a renal transplant recipient. | Martin, Kylie; Roberts, Veena; Chong, Geoffrey ; Goodman, David; Hill, Prue; Ierino, Francesco |
| 15 | 1-Sep-2018 | A Practical Approach to the Use of Conventional Synthetic, Biologic and Targeted Synthetic Disease Modifying Anti-Rheumatic Drugs for the Treatment of Inflammatory Arthritis in Patients with a History of Malignancy. | Wong, Peter K K; Bagga, Hanish; Barrett, Claire; Chong, Geoffrey ; Hanrahan, Patrick; Kodali, Teja; Marabani, Mona; Prince, H Miles; Riordan, John; Swarbrick, Phillip; White, Ray; Young, Laurel |
| 16 | May-2018 | Limited utility of routine chest X-ray in initial evaluation of neutropenic fever in patients with haematological diseases undergoing chemotherapy. | Estacio, Ortis; Loh, Zoe ; Baker, Amy ; Chong, Geoffrey ; Grigg, Andrew P ; Churilov, Leonid ; Hawkes, Eliza A |
| 17 | 21-Mar-2018 | Novel Indications for Bruton's Tyrosine Kinase Inhibitors, beyond Hematological Malignancies. | Campbell, Robert; Chong, Geoffrey ; Hawkes, Eliza A |
| 18 | 2018 | Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI. | Wight, Joel C ; Chong, Geoffrey ; Grigg, Andrew P ; Hawkes, Eliza A |
| 19 | 2018 | Routine blood investigations have limited utility in surveillance of aggressive lymphoma in asymptomatic patients in complete remission. | Hawkes, Eliza A ; Loh, Zoe ; Estacio, Ortis; Chong, Geoffrey ; Ha, Francis J; Gilbertson, Michael; Grigg, Andrew P |
| 20 | Feb-2017 | Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14 | Hertzberg, Mark; Gandhi, Maher K; Trotman, Judith; Butcher, Belinda; Taper, John; Johnston, Amanda; Gill, Devinder; Ho, Shir-Jing; Cull, Gavin; Fay, Keith; Chong, Geoffrey ; Grigg, Andrew P ; Lewis, Ian D.; Milliken, Sam; Renwick, William; Hahn, Uwe; Filshie, Robin; Kannourakis, George; Watson, Anne-Marie; Warburton, Pauline; Wirth, Andrew; Seymour, John F; Hofman, Michael S; Hicks, Rodney J; Australasian Leukaemia and Lymphoma Group (ALLG)
|
Loading...
2
0
20
0
false